Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13543295 | 0.80 | MAPK1 (0.35) | ALDH1A1TDP1CA2CYP2C19KMT2A | |
| SCHEMBL14035478 | 0.80 | MAPK1 (0.35) | ALDH1A1TDP1CA2CYP2C19KMT2A | |
| SCHEMBL1262761 | 0.79 | CYP2C19 (0.43) | ALDH1A1TDP1CA2CYP2C19PTPN1 | |
| SCHEMBL5451205 | 0.78 | CYP2C19 (0.46) | ALDH1A1TDP1CA2CYP2C19SMN1; SMN2 | |
| SCHEMBL20830102 | 0.78 | GABRP (0.37) | ALDH1A1TDP1KMT2A | |
| SCHEMBL5196201 | 0.78 | ALDH1A1 (0.32) | ALDH1A1TDP1KMT2A | |
| SCHEMBL13554068 | 0.78 | ALDH1A1 (0.43) | ALDH1A1TDP1CA2CYP2C19SMN1; SMN2 | |
| SCHEMBL5013963 | 0.78 | ALDH1A1 (0.32) | ALDH1A1TDP1KMT2A | |
| SCHEMBL5196735 | 0.78 | ALDH1A1 (0.32) | ALDH1A1TDP1KMT2A | |
| SCHEMBL5194291 | 0.78 | HSD11B1 (0.32) | ALDH1A1TDP1CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7704929-B2 | Diaromatic amine derivatives as antioxidants | CHEMTURA CORPORATION (US) | 2010-04-27 | — | — | US | claimed |
| US-20070155633-A1 | Diaromatic amine derivatives as antioxidants | LANXESS SOLUTIONS US INC. | 2007-07-05 | — | — | US | claimed |
| EP-1276804-B1 | LIQUID ANTIOZONANTS AND RUBBER COMPOSITIONS CONTAINING SAME | UNIROYAL CHEM CO INC (US) | 2006-06-14 | — | — | EP | claimed |
| US-20050282878-A1 | Process for the purification of fluconazole | GLENMARK PHARMACEUTICALS LIMITED (IN) | 2005-12-22 | — | — | US | claimed |
| US-6706216-B1 | REACTION PRODUCT OF CATALYTIC REDUCTIVE ALKYLATION OF P-PHENYLENEDIAMINE OR DERIVATIVE WITH ACETONE AND SECOND CARBONYL COMPOUND | UNIROYAL CHEMICAL COMPANY, INC. | 2004-03-16 | — | — | US | claimed |
| US-6706217-B2 | OBTAINED FROM THE REACTION OF A PARAPHENYLENEDIAMINE COMPOUND WITH ACETONE AND AT LEAST ONE OF KETONES AND ALDEHYDES, USING A REDUCTIVE ALKYLATION CATALYST | UNIROYAL CHEMICAL COMPANY, INC. | 2004-03-16 | — | — | US | claimed |
| CN-1425037-A | Liquid antiozonants and rubber compositions containing them | UNIROYAL CHEM CO INC (US) | 2003-06-18 | — | — | CN | claimed |
| EP-1276804-A1 | LIQUID ANTIOZONANTS AND RUBBER COMPOSITIONS CONTAINING SAME | Uniroyal Chemical Company, Inc. (US) | 2003-01-22 | — | — | EP | claimed |
| US-20020061946-A1 | Liquid antiozonants and rubber compositions containing same | ADDIVANT USA, LLC | 2002-05-23 | — | — | US | claimed |
| WO-2001081459-A1 | LIQUID ANTIOZONANTS AND RUBBER COMPOSITIONS CONTAINING SAME | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2001-11-01 | — | — | WO | claimed |
| US-20260132232-A1 | OPHTHALMIC DEVICES | BAUSCH LOMB IRELAND LTD (IE) | 2026-05-14 | — | — | US | disclosed |
| EP-3788084-B1 | OPHTHALMIC DEVICES CONTAINING UV BLOCKER AND METHODS FOR THEIR PREPARATION | BAUSCH & LOMB (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12552883-B2 | Ophthalmic devices | BAUSCH + LOMB IRELAND LIMITED (IE) | 2026-02-17 | — | — | US | disclosed |
| EP-4677398-A1 | CONTACT LENS CONTAINING DEPROTECTED ULTRAVIOLET BLOCKERS | Bausch + Lomb Ireland Limited (IE) | 2026-01-14 | — | — | EP | disclosed |
| EP-4646240-A1 | BIOMEDICAL DEVICES HAVING A SURFACE COATING | Bausch + Lomb Ireland Limited (IE) | 2025-11-12 | — | — | EP | disclosed |
| WO-1998050336-A1 | SUPERACID CATALYZED FORMYLATION-REARRANGEMENT OF SATURATED HYDROCARBONS | OLAH GEORGE A (US) | 1998-11-12 | — | — | WO | disclosed |
| US-4900868-A | Process for producing N,N'-disubstituted paraphenylene diamine mixtures by sequential reductive alkylation | MONSANTO COMPANY (US) | 1990-02-13 | — | — | US | disclosed |
| US-4859285-A | SOLVENT EXTRACTIONUSING KETONE | Berg, Lloyd (US) | 1989-08-22 | — | — | US | disclosed |
| US-4666626-A | OXO-HEXYL ACETATE, CYCLOHEXANONE | C.L.M., INC. (US) | 1987-05-19 | — | — | US | disclosed |
| EP-0084527-A2 | Process for producing paraphenylenediamine mixtures | MONSANTO COMPANY (US) | 1983-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050282878-A1 | Process for the purification of fluconazole | ERG28, CYP51A1, MAN2B1 | ALDH1A1 790/4885TDP1 947/4885CA2 401/4885 |
| US-20260132232-A1 | OPHTHALMIC DEVICES | MYO1G, CRY1, UACA | ALDH1A1 2066/4885TDP1 4617/4885CA2 37/4885 |
| US-20070155633-A1 | Diaromatic amine derivatives as antioxidants | C9, C5, C1S | ALDH1A1 462/4885TDP1 2279/4885CA2 4661/4885 |
| US-12552883-B2 | Ophthalmic devices | ILK, MYLK, SMAD2 | ALDH1A1 2118/4885TDP1 4782/4885CA2 2053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.